suppl.pdf)]. Notably, the disease category of mesothelioma was initially introduced into ICD-10 codes comprising subcategories of pleural (C45.0), peritoneal (C45.1), pericardial (C45.2), other sites (C45.7), and unspecified (C45.9). In our study, we defined pleural mesothelioma as a composite of mesothelioma of the pleura (C45.0) and unspecified mesothelioma (C45.9) because in certain countries, including the United States, most mesothelioma was coded as C45.9 instead of C45.0. From the database, we obtained the annual numbers of male deaths for each country, based on 5-year age intervals.
We obtained national population data from the WHO (2006b), the U.S. Census Bureau (2006) , the United Nations (2006) , and Lahmeyer (2007) , prioritized for use in that order. For each country, we calculated age-adjusted annual mortality rates (annual MRs; deaths/million/year) by dividing the number of male deaths in each year by the size of the corresponding male national population, which we age-standardized to the world standard population of the year 2000 (Ahmad et al. 2000) . We similarly calculated period MRs by dividing the average annual number of male deaths from 1996 to 2005 by the average sizes of male national populations, also age-standardized.
To characterize the trend of mortality, we estimated the annual percent change (APC) of annual MRs using the Joinpoint software (version 3.0, U.S. National Cancer Institute, Bethesda, MD, USA). Briefly, the method fits a least-squares regression line to the natural logarithm of the rates using calendar year as a regressor variable. That is, y = bx + c, where y is the ln(rate), x is the calendar year, and c is the intercept. Hence, APC = 100 × (e b -1) (Jemal et al. 2000; Lasithiotakis et al. 2006; Ries et al. 1997 ). In addition, we calculated p-values for APC = 0 and 95% confidence intervals (CIs) of APCs. Testing the hypothesis that APC = 0 is equivalent to testing the hypothesis that the regression slope parameter is equal to zero (Ries et al. 1997 ). We assumed a linear change of trends in log rates over time. Because trends pertained to a 10-year period, we limited analyses to countries with at least 4 years of pleural mesothelioma data under ICD-10 codes (the range was 4-9 years, with a median of 6 years).
Indicators of asbestos use. We extracted data on new use of asbestos by country from a U.S. Geological Survey (USGS) report (Virta 2006 ). We defined "use" as production plus import minus export (Virta 2006) . We considered negative values of use (caused by storage and the like) uninformative and excluded them from further analyses. To characterize trends, we divided use numbers by sizes of national populations for the corresponding year or period (to give use per capita, expressed as kilograms per capita/year) (Lin et al. 2007 ). The USGS database provides data only sparsely in 10-year intervals up to 1960, 5-year intervals from 1970-1995, and annually for 1996-2003 . We classified use of ≥ 3.0 kg per capita/year as high and ≥ 4.0 as very high, and change in use during a particular period (Δ, kilograms per capita/year) as the difference between average use during the earlier and latter subperiods (halves) of the entire period (e.g., for the period 1960-1985, change is the difference between the average use of 1960 and 1970 and the average use of 1975, 1980, and 1985; for the period 1970-1985 , change is the difference between the average use of 1970 and 1975 and the average use of 1980 and 1985) . We calculated Δ values for all possible combinations of available data. We retrieved national ban status from the database compiled by Kazan-Allen (2005 and verified it by separate reports. To describe historical trends in asbestos use and relationships with banning status, we grouped countries according to their national ban status into early-ban (adopted by 1995), late-ban (1996-2006) , and no-ban groups.
Statistical analysis. We adapted geographic grouping of countries from the U.N. Statistics Division (United Nations 2006). We performed statistical analyses using Joinpoint, SPSS version 12.0 (SPSS Inc., Chicago, IL, USA), and Excel 2003 (Microsoft Corp., Redmond, WA, USA). When we used Joinpoint, we assumed a linear change (or 0 joinpoint) during the observed period, with a maximum length of 10 years. We deemed p < 0.05 statistically significant and 0.05 < p < 0.10 marginally significant. We use the terms "increase" (denoted as ↑) or "decrease" (↓) when APC was marginally or statistically significant, and "equivocal" (↔) when APC and its significance level were neither statistically nor marginally significant.
When we evaluated trends in asbestos use by groups of countries, we weighted means by the size of national populations of the corresponding periods. We analyzed data from Asbestos use fell most quickly in countries that adopted early bans, at an intermediate rate in countries with late ban adoption, and most slowly in countries without bans (Figure 1) . Specifically, the early-ban group, during its period of adopting bans, recorded a reduction rate of -8.3%/year, from 2.4 kg per capita/year in 1983 (first ban) to < 0.01 kg per capita/year in 1995 (last ban). This was about twice as fast as the late-ban and no-ban groups, which recorded a reduction rate of -4.1%/year and -5.2%/year, respectively, during the same period. Similarly, the late-ban group, during its period of adopting bans, recorded a reduction rate of -10.7%/year, from 0.7 kg per capita/year in 1996 (first ban) to 0.2 kg per capita/year in 2003. During the same period, the value for the no-ban group was -4.9%/year, resulting in a 2.2-fold quicker reduction rate in the late-ban group. The historical use pattern of the United States differed from that of other countries. The United States recorded the earliest and maximal peak use at 4.2 kg per capita/year in 1950, followed by progressive reduction over four decades and approaching 0.02 kg per capita/year in 2003, equating to a reduction rate of -1.9%/year. The no-ban group had the lowest peak but currently maintains the highest level of asbestos use at 0.4 kg per capita/year. The period of 1970-1985 contained historical use peaks with a notable shift to downward trends for many but not all countries.
Results

Trends in mortality.
Interrelationships. The change in asbestos use (Δ) during 1970-1985 was the strongest predictor of APC among the many periods tried, with an adjusted R 2 value of 0.47 (p < 0.0001) ( Table 3 ). Changes in asbestos use during other adjacent periods (e.g., 1960-1990, 1970-1990 ) also predicted APC in mortality, each with relatively high statistical significance. Figure 2 shows the positive log-linear relationships between changes in asbestos use and APCs in mortality, where increments in recent MRs are associated with increments in historical asbestos use.
Discussion
The present study identified wide differences in recent mortality from pleural mesothelioma in various countries. Recent MRs were highest in the countries of Northern and Western Europe and Oceania. Increasing Abbreviations: NA 1, data not available; NA 2, not applicable because of negative use data: 0.00 when the calculated data were < 0.005; 0 if there are no data after the year the ban was introduced. See Table 1 for country codes. a Numbers corresponding to use of asbestos by country and region were calculated as annual use per capita averaged over the respective decade. b Change in use (Δ, kilograms per capita/year) during the period defined as the difference between the average of consumption during the former subperiod (1970) (1971) (1972) (1973) (1974) (1975) and latter subperiod (1980) (1981) (1982) (1983) (1984) (1985) . c Year first achieved or year planned to achieve ban. When shown as fraction, the numerator is the number of countries that achieved bans and the denominator is the number of other countries in the region. d Data on asbestos use were available (but mortality data unavailable) for others in each region, in which case data were aggregated.
trends, as measured by APCs in mortality, were common in the countries of Eastern and Southern Europe, Asia, and South America. We assessed mortality trends over the most recent 10-year window, using the earliest opportunity to analyze the disease under the standard code of ICD-10. However, the study period was inadequate to depict trends in many countries. National data recorded only under ICD-9 had to be precluded (e.g., Italy). For the countries shifting from ICD-9 to ICD-10 during the study period, we limited our analyses to the period when data were recorded under ICD-10.
Further, data may lack comparability, especially because mesothelioma is rare and difficult to diagnose. A major concern is that increasing trends recorded in countries with low mortality levels could be explained by improved disease recognition (Peto et al. 1995; Weill et al. 2004) , and such secular trends in diagnosis would be statistically indistinguishable from real increases (Peto et al. 1995) . Our study revealed increasing mortality trends in the group that recorded abovemedian values for the period MR (group 1) than the group that recorded below-median values for the period MR (group 2). Such bias is likely to be less serious in group 1 than group 2. Thus, although increases in disease recognition are probable, this factor alone does not explain the increasing trends. The proportionality with which recent mortality trends were related to historical trends of asbestos use offers a more compelling explanation.
Pleural mesothelioma is the predominant type of mesothelioma and is strongly related to asbestos exposure. However, in certain countries, most mesothelioma was coded into the subcategory of unspecified mesothelioma (C45.9) instead of the subcategory of pleural mesothelioma (C45.0): the ratio of C45.0 to C45.0 + C45.9 ranged from 0.08 (Israel), 0.11 (United States), and 0.12 (Canada) to 0.94 (New Zealand) and 0.98 (Finland), with a median of 0.63. We therefore created a composite category of C45.0 and C45.9 to ensure comparability, which we deemed more reasonable than the alternative choices of analyzing only C45.0 or mixing C45.0 with other subcategories-for example, peritoneal (C45.1) or pericardial (C45.2) or other sites (C45.7).
Our findings on mortality trends are comparable with trends reported earlier for individual countries, including the Netherlands (Segura et al. 2003) , Sweden (Burdorf et al. 2005) , Finland (Karjalainen et al. 1997) , and Denmark (Kjaergaard and Andersson 2000) , as well as overall Europe (Montanaro et al. 2003) . However, methods and indices employed to evaluate trends are unique to each study, and comparisons cannot exceed the general trend characteristics. For the United States, we recorded equivocal trends (i.e., APC = 0.8%). Similarly, Price (1997) first observed that the annual growth rate during 1973-1992 was declining, and Price and Ware (2004) term (1960s-1980s ) very high peak, followed by an abrupt decline (Australia and several Northern and Western European countries); and c) a late (≥ 1980) and relatively moderate peak followed by a moderate decline (Hungary and Japan).
In the United States, a "bubble" in asbestos use occurred in the mid-20th century because of early manufacturing research, industrial demand, and ready supply from Canada (Virta 2006) . However, the United States was also the first to experience the burst of the bubble due to growing health concerns and liability issues (Virta 2006) . In 1989, the U.S. Environmental Protection Agency (EPA) banned most asbestos-containing products, but this regulation was overturned by the U.S. Court of Appeals in 1991 (U.S. EPA 1989). Nevertheless, use fell to 4,600 tons in 2003 (0.7% of peak use). In many other countries, increasing use of asbestos paralleled the growth curves of industrialization.
Generally, countries recording early and high levels of asbestos use displayed peaks by 1980 followed by downward trends. The turning points preceded the earliest bans and are thus not direct outcomes of bans. Rather, paths leading to bans likely entailed regulatory restrictions and economic incentives and disincentives, which furthered reduction of use. Virta (2005 Virta ( , 2006 attributed maturation of the asbestos market superimposed on health issues as the main reason for the decline in use since 1980. Several relevant events with international impact coincided with this period. The International Agency for Research on Cancer (IARC), after acknowledging the carcinogenicity of asbestos in 1973 (IARC 1973) , classified asbestos as a human carcinogen in 1977 carcinogen in (IARC 1977 . The ILO added lung cancer and mesothelioma caused by asbestos to its list of occupational diseases in 1980 (ILO 1980 ) and adopted the Asbestos Convention in 1986 (ILO 1986). It was also around this period that the landmark studies by Selikoff and colleagues (Nicholson et al. 1982; Selikoff et al. 1984a Selikoff et al. , 1984b ) gained wide recognition.
The adoption of bans by Northern European countries in the 1980s set a precedent for other countries, but the particular restrictions imposed by a "ban" vary by country, and the rates at which the absolute zero use levels were reached also vary. Collectively, countries adopting bans reduced use about twice as fast as those with lesser interventions. Notably, the countries of Eastern and Southern Europe (grouped here as "other" countries in Table 2 ) have continued to use asbestos, approaching high levels even after the turn of the century. The recent per capita use for the "other" Asian countries is low but shows little sign of decreasing. This is largely attributable to sustained use in China and India. Hence, our findings reinforce the widely held concern that the center of asbestos use is shifting to industrializing countries (Kazan-Allen 2005; LaDou 2004; Takahashi and Karjalainen 2003) . Moreover, if the ecologic relationship reported here holds true for the future, corresponding risks should be anticipated in these countries.
Regression analyses showed the strongest relationship between recent APC in mortality from pleural mesothelioma and change in asbestos use during 1970-1985 (adjusted R 2 = 0.47, p < 0.0001). The same analyses incorporating countries with six or more data points produced similar results (data not shown). The strong relationship is largely attributable to countries recording recent mortality trends in the same direction as historical use trends (lower-left and upper-right quadrants in Figure 2 ). The positive correlations found for change indicators of a number of periods in the present study reinforce the notion that per capita asbestos use is related to subsequent mortality level at the national level, as we reported earlier using absolutelevel indicators (Lin et al. 2007 ). However, the time difference (i.e., latency) for the best predictive model was only 22.5 years (from mid-1977 to 2000) , and thus the observed relationship may have reflected only early effects. In this connection, recent mortality trends of the eight early-ban countries are noteworthy: Seven countries recorded had equivocal MR trends, and only Germany had an increase in MR trend (Table 1) . Germany actually recorded a historical use peak in 1980, trailing other early-ban countries by 5-10 years (detailed data not shown) and presumably delaying favorable changes in mortality trend. Continuing use of asbestos results in the accumulation of asbestos in the environment, thus creating possibilities for ongoing exposure due to maintenance, repair, and demolition during the entire life span of asbestos products. Given the long latency time, the mortality data available did not allow us to analyze the full consequences of such effects after the new use in longer term. Nevertheless, we observed significant (albeit weaker) relationships for changes in use during other close periods with longer latencies [e.g., 1950-1985 (latency 32.5 years) and 1950-1990 (30 years)] .
In this study, we took advantage of the earliest opportunity to analyze mortality trends in a range of countries. Limitations included our dependence on a crude indicator of exposure (i.e., asbestos use per capita for sparse years with limited data), "bans" entailing varying restrictions on use that could not be measured, and no distinctions available Table 1 for country codes. Circles have areas proportional to the sizes of male national populations; the smaller equal sizes indicate male national populations < 5,000,000. We defined the trend of MRs (y-axis) as APC, as calculated by the Joinpoint software. Bivariate relationships were examined by linear regression, weighted by the sizes of male national populations, and produced the following model: y = 0.011x + 2.022 (adjusted R 2 = 0.47, p < 0.0001). 
